# Regulation (EU) 2020/1043 of the European Parliament and of the Council of 15 July 2020 on the conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or prevent coronavirus disease (COVID-19) (Text with EEA relevance), Signature

Extent: E+W+S+N.I.

This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 15 July 2020.
For the European Parliament
The President
D. M. Sassoli
For the Council
The President
J. Kloeckner

---
Source: https://www.legislation.gov.uk/eur/2020/1043/signature (the official version)
Page: https://openlegislation.uk/eu-regulation-2020-1043/signature
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.